Biomarker Model Predicts Three-Month Mortality in Advanced Light-Chain Cardiac Amyloidosis
Researchers developed a predictive model combining NT-proBNP and neutrophil-to-platelet ratio to assess three-month mortality risk in advanced light-chain cardiac amyloidosis.

